POMDOCTOR LIMITED: updates and filings

POMNASDAQConsumer cyclical · Retail-Miscellaneous Retail

Price

$1.54

November 19, 2026

What Ploutos Investor adds for POMDOCTOR

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 3 fiscal years, from 2023
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price was recently adjusted for a split or a spin-off that the company's last filing does not include yet. Market value, P/E, yields and the other figures measured against the price would mix the new shares with the old figures, so we leave them out until the next filing.
  • The debt we can read is far below what the company's own annual report says falls due over the coming years, so most of its borrowing is in figures we cannot read. We leave out the debt, net cash, enterprise value and the multiples built on them.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

May 14, 2026 latest annual
  • Nov 6, 2026Current report (foreign company)
    Form6-K
  • Nov 4, 2026Current report (foreign company)
    Form6-K
  • Nov 2, 2026Current report (foreign company)
    Form6-K
  • Oct 19, 2026Current report (foreign company)
    Form6-K
  • Oct 9, 2026Current report (foreign company)
    Form6-K
  • Oct 2, 2026Current report (foreign company)
    Form6-K
  • Sep 30, 2026Current report (foreign company)
    Form6-K
  • Sep 29, 2026Current report (foreign company)
    Form6-K
  • Sep 24, 2026Current report (foreign company)
    Form6-K
  • Sep 10, 2026Current report (foreign company)
    Form6-K
  • Sep 4, 2026Current report (foreign company)
    Form6-K
  • Aug 27, 2026Current report (foreign company)
    Form6-K
  • Aug 10, 2026Current report (foreign company)
    Form6-K
  • Aug 3, 2026Current report (foreign company)
    Form6-K
  • Jul 28, 2026Shares registered for employees
    FormS-8
  • Jul 15, 2026Current report (foreign company)
    Form6-K
  • Jul 13, 2026Current report (foreign company)
    Form6-K
  • Jul 9, 2026Current report (foreign company)
    Form6-K
  • Jul 2, 2026Current report (foreign company)
    Form6-K
  • Jun 17, 2026Current report (foreign company)
    Form6-K
  • May 28, 2026Filing
    FormF-6 POS
  • May 28, 2026Current report (foreign company)
    Form6-K
  • May 14, 2026Current report (foreign company)
    Form6-K
  • May 14, 2026Annual report (foreign company)for the period to Dec 31, 2025
    Form20-F
  • Apr 30, 2026Notice that the annual report will be filed late
    FormNT 20-F

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Sep 30, 2021.

The full analysis

What do POMDOCTOR's filings show?

The filings are where every one of POMDOCTOR's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.